Table 2.
Demographic and clinical characteristics according to FBS groups.
| Variables | Overall cohort (n = 91) | Group I (n = 47) | Group II (n = 44) | Effect Size (95% CI) | p-value |
|---|---|---|---|---|---|
| Age at assessment, years | 11 [10–14] | 12 [10–14] | 11 [10–14] | −0.03 (−0.27–0.21) | 0.80 |
| Female sex, n (%) | 35 (38.5) | 17 (36.1) | 18 (40.9) | 0.82 (0.35–1.91) | 0.67 |
| Family history of FMF, n (%) | 56 (61.5) | 31 (65.9) | 25 (56.8) | 1.47 (0.63–3.44) | 0.40 |
| M694V homozygous genotype, n (%) | 25 (27.5) | 13 (27.6) | 12 (27.2) | 1.02 (0.41–2.56) | 0.97 |
| Age at symptom onset (months) | 59 [27–89] | 60 [33–88] | 54 [24–88] | 0.06 (−0.17–0.29) | 0.61 |
| Age at diagnosis (months) | 75 [48–112] | 76 [47–100] | 75 [51–120] | −0.09 (−0.32–0.15) | 0.47 |
| Delay in diagnosis (months) | 11 [6–25] | 10 [6–24] | 12 [7–31] | −0.11 (−0.33–0.13) | 0.38 |
| Follow-up duration (months) | 50 [16–77] | 57 [25–77] | 38 [16–73] | 0.09 (−0.15–0.31) | 0.49 |
| BMI (kg/m²) | 19.5 ± 4.3 | 20.5 ± 3.8 | 18.3 ± 4.5 | 0.51 (0.10–0.93) | 0.02 |
| BMI percentile (≥85%) | 26 (28.6) | 16 (34.0) | 10 (22.7) | 1.75 (0.69–4.44) | 0.24 |
| Pras disease severity score | 6.6 ± 2.2 | 6.8 ± 2.2 | 6.5 ± 2.0 | 0.17 (−0.24–0.58) | 0.41 |
| Number of attacks in the previous year | 1.0 [0.0–3.0] | 1.0 [0.0–3.0] | 0.0 [0.0–2.2] | 0.04 (−0.20–0.27) | 0.82 |
| Colchicine dose (mg/kg/day) | 0.024 ± 0.013 | 0.023 ± 0.014 | 0.024 ± 0.011 | −0.09 (−0.52–0.33) | 0.66 |
| Fever, n (%) | 61 (67.0) | 32 (68.0) | 29 (65.9) | 1.10 (0.46–2.65) | 0.83 |
| Abdominal pain, n (%) | 79 (86.8) | 42 (89.3) | 37 (84.0) | 1.59 (0.46–5.44) | 0.54 |
| Chest pain, n (%) | 9 (9.9) | 5 (10.6) | 4 (9.09) | 1.19 (0.30–4.75) | 0.81 |
| Arthritis, n (%) | 21 (23.1) | 14 (29.7) | 7 (15.9) | 2.24 (0.81–6.23) | 0.14 |
| Exertional leg pain, n (%) | 46 (50.5) | 29 (61.7) | 17 (38.6) | 2.56 (1.10–5.96) | 0.04 |
| Colchicine resistance, n (%) | 18 (19.8) | 12 (25.5) | 6 (13.6) | 2.17 (0.74–6.41) | 0.19 |
Higher FBS scores indicate healthier food choices. Group I included patients with scores ≤0, representing less favorable eating behavior, and Group II included patients with scores >0, representing more favorable eating behavior.
BMI, Body Mass Index; CI, Confidence interval; FBS, Food Behavior Scale; FMF, Familial Mediterranean Fever; OR, Odds ratio.
Data are presented as mean ± standard deviation, median [interquartile range], or n (%), as appropriate. Continuous variables were compared using the independent-samples t-test or Mann–Whitney U-test, and categorical variables were compared using the Pearson chi-square or Fisher exact test. Hedges' g, rank-biserial correlation, and ORs were reported as effect-size measures for parametric continuous, nonparametric continuous, and binary categorical variables, respectively.